Renalytix AI (RNLX)
(Real Time Quote from BATS)
$0.34 USD
+0.02 (5.26%)
Updated Aug 26, 2024 12:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Renalytix AI PLC Sponsored ADR [RNLX]
Reports for Purchase
Showing records 1 - 19 ( 19 total )
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
KidneyIntelX Platform Expands Into Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Medicare Issues Final Coverage Determination; Reiterate Buy; Lowering PT to $3
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
KidneyIntelX Obtains De Novo Marketing Clearance; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
F2Q23 Financial Results Reported; Reiterate Buy; Lowering PT to $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
VA Health System Integration Executed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Fiscal 1Q23 Financial Results Reported; Reiterate Buy; Lowering PT to $8
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Fiscal Year 2022 Financial Results Reported; Reiterate Buy; Lowering PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
New Clinical Utility Study Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
F3Q22 Financial Results Reported; Reiterate Buy; Lowering PT to $15
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Real-World Clinical Utility of KidneyIntelX Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Risk Stratification Data in Diabetic Kidney Disease Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Biobank Program Reaches Enrollment Milestone; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
National Physician Access Platform Launched; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
KidneyIntelX Clinical Data Presented; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
Unique Bioprognosis for Kidney Health; Initiating at Buy and $30 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Renalytix AI PLC Sponsored ADR
Industry: Computers - IT Services
|